skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Radioimmunoscintigraphy and radioimmunotherapy of renal cell carcinoma xenografts

Journal Article · · NCI Monogr.; (United States)
OSTI ID:6523877

From a panel of monoclonal antibodies (MAb) reactive with human renal cell carcinoma generated by this laboratory, three (designated A6H, C5H, and D5D) were selected for in vivo studies with a nude mouse xenograft model. These studies included /sup 131/I- and /sup 111/In-labeled MAb radioimmunoscintigraphy and /sup 131/I-labeled MAb radioimmunotherapy. In the imaging studies, these radiolabeled MAb allowed visualization of subcutaneous xenografts larger than 40 mg and subrenal capsule xenografts smaller than 20 mg. Comparisons of tumor to non-tumor tissue radiolabel distribution yielded unusually high ratios and depended on the MAb-xenograft combination. The /sup 111/In-radiolabeled A6H showed increased accumulation in the liver compared with /sup 131/I-A6H, but this still did not necessitate background subtraction for good visualization of small, subrenal capsule renal cell carcinoma xenografts. Radioimmunotherapy studies with /sup 131/I-A6H in BALB/c nu/nu mice bearing established renal cell carcinoma xenografts showed a prolonged (greater than 90 days) regression in tumor burden and possible cures, whereas three sets of control mice showed progressive and rapid increases in tumor size. These studies indicated that MAb, which show good tissue biodistribution and high imaging sensitivity, could also be capable of delivering effective radiotherapy to the tumor when human equivalent radiolabeled-MAb doses are used.

Research Organization:
Veterans Administration Medical Center, Minneapolis, MN
OSTI ID:
6523877
Journal Information:
NCI Monogr.; (United States), Vol. 3
Country of Publication:
United States
Language:
English

Similar Records

Radioimmunoscintigraphy and radioimmunotherapy with RCC MABS
Conference · Wed May 01 00:00:00 EDT 1985 · J. Nucl. Med.; (United States) · OSTI ID:6523877

Biodistribution and radioimmunoscintigraphy studies of renal cell carcinoma using tumor-preferential monoclonal antibodies and F(ab')2 fragments
Journal Article · Fri Dec 01 00:00:00 EST 1989 · Journal of Urology; (USA) · OSTI ID:6523877

Study of the diagnosis and treatment of renal cell carcinoma using monoclonal antibodies
Thesis/Dissertation · Thu Jan 01 00:00:00 EST 1987 · OSTI ID:6523877